** Shares of Next Science Ltd NXS.AX rise as much as 2.8% to
A$0.735, on track to see their best day since Oct 19, if gains
hold
** Medical technology company says co recorded Q3 product
sales of $3.0 mln, up 43% on prior corresponding period
urn:newsml:reuters.com:*:nASX80C3hW
** Says co recorded revenue of $3.14 mln for Q3 compared to
$2.2 mln previous year
** Says revenue was driven by ongoing market adoption of
co's wound care and surgical infection control products
** Says co sees positive outlook with accelerating sales and
marketing activities across multiple product and sales channels
for Q4
** Shares of co are down 42.6% YTD as of last close
(Reporting by John Biju in Bengaluru)
((John.Biju@thomsonreuters.com;))